Ghent University Academic Bibliography

PhD Thesis

Targeting chitinase-like proteins to overcome immune checkpoint blockade resistance in heterogeneous triple-negative mammary tumors

Robbe Salembier (UGent)

(2026)

Journal Article
A1
open access

A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment

Ioulia Vogiatzi (UGent) , Amelia Lehmann, Chuang Liu, Lucia Moreno-Lama, Yoshinori Kajiwara, Nobuhiko Kanaya, Olivier Zwaenepoel (UGent) , Ali Salehi Farid, Uk-Jae Lee, Filippo Rossignoli, et al.

(2026) EBIOMEDICINE. 124.

Add to list

Journal Article
A1
open access

Cell-based immunization combined with single-round cell panning enables discovery of PSMA-targeting nanobodies from phage display libraries

Tong Yang (UGent) , Joke Veldhoven-Zweistra, Maarten Ligtenberg, Sigrun Erkens, Mirella Vredenbregt-van den Berg, Rick Jansen, Patrick Chames, Eric M. J. Bindels, Khadijeh Ahmadi, Chris H. Bangma, et al.

(2026) BIOMOLECULES. 16(2).

Add to list

Design, engineering, and functional evaluation of nanobody-based anti-CD73 for immunogenic cell death induction in chemoresistant colorectal cancer cell line

Hamid Aria, Hamid Bakherad, Ahmadreza Mehdipour (UGent) , Mahdieh Azizi and Marzieh Rezaei

(2026) INTERNATIONAL IMMUNOPHARMACOLOGY. 172.

Add to list

Journal Article
A1
open access

Quality of life measures in advanced endometrial cancer : a systematic review of reporting practices in phase III clinical trials

Justine Himpe (UGent) , Marjolein Orije (UGent) , Emiel De Jaeghere (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2026) CANCERS. 18(2).

Add to list

Multivalent antibody-recruiting molecules for targeted immune-killing of carbonic anhydrase IX-expressing cancer cells

Haixia Peng, Jamie De Baere (UGent) , Federica Cappellesso, Kieran English (UGent) , Kim Deswarte (UGent) , Damya Laoui, Bart Lambrecht (UGent) , Bruno De Geest (UGent) and Benoit Louage (UGent)

(2026) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION.

Add to list

Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peritoneal metastases

Huan Yan (UGent) , Daryl Chia, Sam Ernst (UGent) , Jesse Demuytere (UGent) , Sarah Cosyns (UGent) and Wim Ceelen (UGent)

(2026) EXPERT OPINION ON DRUG DELIVERY. 23(7). p.1211-1230

Add to list

Journal Article
A1
open access

Cationic mRNA lipid nanoparticles for ex vivo NanoCAR‐T cell engineering

Laure Harinck (UGent) , Stijn De Munter (UGent) , Margo De Velder (UGent) , Joline Ingels (UGent) , Dominika Berdecka, Ine Lentacker (UGent) , Winnok H. De Vos, Bart Vandekerckhove (UGent) , Kevin Braeckmans (UGent) and Koen Raemdonck (UGent)

(2026) ADVANCED SCIENCE. 13(24).

Add to list

Miscellaneous

Cell surface proteomics of patient-derived malignant rhabdoid tumor organoids identifies ROBO1 as potential CAR T cell target for pediatric solid tumors

Juliane L. Buhl, Jannet Koelewijn, Stijn De Munter (UGent) , Victoria M. Cruz, Daryl Jun Kai Chin, Baojie Zhang, Marliek van Hoesel, Nienke van Herk, Irene Paassen, Katie Nachataya, et al.

(2025) bioRxiv.

Add to list

Journal Article
A1
open access

MHCquant2 refines immunopeptidomics tumor antigen discovery

Jonas Scheid, Steffen Lemke, Naomi Hoenisch-Gravel, Anna Dengler, Timo Sachsenberg, Arthur Declercq (UGent) , Ralf Gabriels (UGent) , Jens Bauer, Marcel Wacker, Leon Bichmann, et al.

(2025) GENOME BIOLOGY. 26(1).

Academic Bibliography

Targeting chitinase-like proteins to overcome immune checkpoint blockade resistance in heterogeneous triple-negative mammary tumors

A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment

Cell-based immunization combined with single-round cell panning enables discovery of PSMA-targeting nanobodies from phage display libraries

Design, engineering, and functional evaluation of nanobody-based anti-CD73 for immunogenic cell death induction in chemoresistant colorectal cancer cell line

Quality of life measures in advanced endometrial cancer : a systematic review of reporting practices in phase III clinical trials

Multivalent antibody-recruiting molecules for targeted immune-killing of carbonic anhydrase IX-expressing cancer cells

Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peritoneal metastases

Cationic mRNA lipid nanoparticles for ex vivo NanoCAR‐T cell engineering

Cell surface proteomics of patient-derived malignant rhabdoid tumor organoids identifies ROBO1 as potential CAR T cell target for pediatric solid tumors

MHCquant2 refines immunopeptidomics tumor antigen discovery

Contents

Support

Contact